Metraipolis › archive › dc_524909ab2f53

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury — Europe PMC PMID:36279295

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36279295
DOI
10.1371/journal.pone.0276649
License (as archived)
CC0-1.0
Archived
2026-10-16T03:25:22.694Z
SHA-256 of the archived text
bebd1d8e04ba06a1c87d92524db0904f6087f9ed39b0a848ae27d3be13f0554c
Stable URL of this page
https://metraipolis.com/documento/dc_524909ab2f53

How to cite

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury — Europe PMC PMID:36279295 — Europe PMC (en), https://europepmc.org/article/MED/36279295 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_524909ab2f53 (Metraipolis archive dc_524909ab2f53, sha256 bebd1d8e04ba06a1c87d92524db0904f6087f9ed39b0a848ae27d3be13f0554c)
BibTeX
@misc{dc524909ab2f53,
  title = {Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury — Europe PMC PMID:36279295},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36279295},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_524909ab2f53; sha256 bebd1d8e04ba06a1c87d92524db0904f6087f9ed39b0a848ae27d3be13f0554c},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36279295. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Genetic variants in apolipoprotein L1 (APOL1), a protein that protects humans from infection with African trypanosomes, explain a substantial proportion of the excess risk of chronic kidney disease affecting individuals with sub-Saharan ancestry. The mechanisms by which risk variants damage kidney cells remain incompletely understood. In preclinical models, APOL1 expressed in podocytes can lead to significant kidney injury. In humans, studies in kidney transplant suggest that the effects of APOL1 variants are predominantly driven by donor genotype. Less attention has been paid to a possible role for circulating APOL1 in kidney injury. Methods: Using liquid chromatography-tandem mass spectrometry, the concentrations of APOL1 were measured in plasma and urine from participants in the Seattle Kidney Study. Asymmetric flow field-flow fractionation was used to evaluate the size of APOL1-containing lipoprotein particles in plasma. Transgenic mice that express wild-type or risk variant APOL1 from an albumin promoter were treated to cause kidney injury and evaluated for renal disease and pathology. Results: In human participants, urine concentrations of APOL1 were correlated with plasma concentrations and reduced kidney function. Risk variant APOL1 was enriched in larger particles. In mice, circulating risk variant APOL1-G1 promoted kidney damage and reduced podocyte density without renal expression of APOL1. Conclusions: These results suggest that plasma APOL1 is dynamic and contributes to the progression of kidney disease in humans, which may have implications for treatment of APOL1-associated kidney disease and for kidney transplantation.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-10-24).
Identificativi: PMID 36279295 · PMCID PMC9591058 · DOI 10.1371/journal.pone.0276649.
Descrittori MeSH principali: Renal Insufficiency, Chronic; Apolipoprotein L1.
Pagina: https://europepmc.org/article/MED/36279295 — https://doi.org/10.1371/journal.pone.0276649. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-16T03:08:10.617Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.